XML 30 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' Equity
 12 Months Ended
Dec. 28, 2018
Stockholders' Equity Note [Abstract]  
Stockholders' Equity
Note 8: Stockholders’ Equity
 
Preferred Stock
 
The Company has authorized 2,000,000 shares of undesignated preferred stock with a par value of $0.001 per share. None of the preferred shares were issued and outstanding at December 28, 2018 and December 29, 2017.
 
Dividends
 
The Company declared and paid cash dividends per common share during the periods presented as follows:
 
 
 
Fiscal Year 2018
 
 
 
Dividends
 
 
Amount
 
 
 
Per Share
 
 
(in thousands)
 
First Quarter
 
$
0.13
 
 
$
6,700
 
Second Quarter
 
$
0.13
 
 
 
6,764
 
Third Quarter
 
$
0.13
 
 
 
6,765
 
Fourth Quarter
 
$
0.13
 
 
 
6,723
 
 
 
 
 
 
 
$
26,952
 
 
 
 
Fiscal Year 2017
 
 
 
Dividends
 
 
Amount
 
 
 
Per Share
 
 
(in thousands)
 
First Quarter
 
$
0.105
 
 
$
5,374
 
Second Quarter
 
$
0.105
 
 
 
5,424
 
Third Quarter
 
$
0.105
 
 
 
5,424
 
Fourth Quarter
 
$
0.105
 
 
 
5,416
 
 
 
 
 
 
 
$
21,638
 
 
On January 31, 2019, the Company’s Board of Directors announced a cash dividend of $0.16 per share of the Company’s common stock, payable March 22, 2019, to stockholders of record as of March 8, 2019. The Company expects to continue paying quarterly dividends in the future, subject to declaration by the Company’s Board of Directors.
 
Treasury Stock
 
Net losses related to the re-issuance of treasury stock to settle restricted stock unit and stock option awards of $5,892,000, $5,667,000 and $5,791,000 were recorded as a reduction to retained earnings during 2018, 2017 and 2016, respectively.
 
Repurchase of Common Stock
 
The Company repurchased 562,000 shares of its common stock for $27,915,000 during 2018. The Company repurchased 372,000 shares of its common stock for $11,931,000 during 2017. The Company repurchased 982,000 shares of its common stock for $24,456,000 during 2016. On October 18, 2016 the Board of Directors authorized $35,000,000 for the repurchase of Exponent’s common stock. On October 20, 2015 the Board of Directors authorized $35,000,000 for the repurchase of Exponent’s common stock. These repurchase programs have no expiration dates. As of December 28, 2018, the Company had remaining authorization under its stock repurchase plan of $17,462,000 to repurchase shares of common stock.